To test our hypothesis, we treated CRC cells under 2D and 3D culture conditions with increasing concentrations of the EGFR tyrosine kinase inhibitor AG1478 for 48 or 96 hours and determined cell viability by using the MTT assay. Here, EGFR is linked to colorectal carcinoma.